APA (7th ed.) Citation

ND, S., BA, M., MS, C., DR, S., R, T., B, B., . . . F, S. (2023). Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer. Advances in therapy, 40(11), 4919. https://doi.org/10.1007/s12325-023-02634-7

Chicago Style (17th ed.) Citation

ND, Shore, et al. "Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix Vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer." Advances in Therapy 40, no. 11 (2023): 4919. https://doi.org/10.1007/s12325-023-02634-7.

MLA (9th ed.) Citation

ND, Shore, et al. "Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix Vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer." Advances in Therapy, vol. 40, no. 11, 2023, p. 4919, https://doi.org/10.1007/s12325-023-02634-7.